Home
Conditions
Amyotrophic Lateral Sclerosis

Clinical trial condition

Amyotrophic Lateral Sclerosis

Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.

707 public trials 173 recruiting studies

Refine in advanced search Browse all conditions

Amyotrophic Lateral Sclerosis trial results

Not Yet Recruiting

Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS)

NCT05880563

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Muskelzentrum/ALS-Clinic, Kantonsspital St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation

NCT01925196

Conditions: Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

NCT07047209

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Nova Southeastern University Davie, Florida, United States

Northwestern Universsity Chicago, Illinois, United States

MGH Boston, Massachusetts, United States

View Trial Details

Completed

Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP

NCT05562960

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT00330681

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III

NCT00415519

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis

NCT01492686

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Osaka, Japan

View Trial Details

Completed

Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00424463

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: National Hospital Organization Miyagi National Hospital Watari-gun, Miyagi, Japan

View Trial Details

Completed

Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT04577404

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center Phoenix, Arizona, United States

Neuromuscular Research Center Phoenix, Arizona, United States

Woodland Research Northwest Rogers, Arkansas, United States

University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

View all 44 locations

View Trial Details

Completed

Study of Home Use of the Jaco Robotic Manipulation Device by Individuals With Tetraplegia

NCT07680361

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Autoimmune Diseases, +33 more
Locations: Centre Bouffard Vercelli Perpignan, France

View Trial Details

Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis trial results

Related conditions